These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 8940995)
1. Hormones, vitamins, and growth factors in cancer treatment and prevention. A critical appraisal. Lupulescu AP Cancer; 1996 Dec; 78(11):2264-80. PubMed ID: 8940995 [TBL] [Abstract][Full Text] [Related]
2. The role of vitamins A, beta-carotene, E and C in cancer cell biology. Lupulescu A Int J Vitam Nutr Res; 1994; 64(1):3-14. PubMed ID: 8200745 [TBL] [Abstract][Full Text] [Related]
4. New approaches to the therapy of various tumors based on peptide analogues. Schally AV Horm Metab Res; 2008 May; 40(5):315-22. PubMed ID: 18491250 [TBL] [Abstract][Full Text] [Related]
6. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Raju J; Mehta R Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873 [TBL] [Abstract][Full Text] [Related]
7. New treatment approaches for prostate cancer based on peptide analogues. Stangelberger A; Schally AV; Djavan B Eur Urol; 2008 May; 53(5):890-900. PubMed ID: 18201818 [TBL] [Abstract][Full Text] [Related]
8. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Zumkeller W; Schofield PN Anticancer Res; 1995; 15(2):343-8. PubMed ID: 7763004 [TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors and breast cancer. Miller WR Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362 [TBL] [Abstract][Full Text] [Related]
10. Control of precancer cell transformation into cancer cells: its relevance to cancer prevention. Lupulescu AP Cancer Detect Prev; 1996; 20(6):634-7. PubMed ID: 8939350 [TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). Miyazawa T; Shibata A; Sookwong P; Kawakami Y; Eitsuka T; Asai A; Oikawa S; Nakagawa K J Nutr Biochem; 2009 Feb; 20(2):79-86. PubMed ID: 19071006 [TBL] [Abstract][Full Text] [Related]
13. Cancer Drug Development: New Targets for Cancer Treatment. Curt GA Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987 [TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
15. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
16. Second International Symposium on Hormonal Manipulation of Cancer: Peptides, Growth Factors and (Anti) Steroidal Agents. 9,10, and 11 April 1990, Rotterdam, The Netherlands. Abstracts. Eur J Cancer; 1990 Feb; 26(2):143-97. PubMed ID: 2138909 [No Abstract] [Full Text] [Related]
17. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review). Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775 [TBL] [Abstract][Full Text] [Related]
18. Relationship of hormones and growth factors to colon cancer. Conteas CN; Desai TK; Arlow FA Gastroenterol Clin North Am; 1988 Dec; 17(4):761-72. PubMed ID: 3068140 [TBL] [Abstract][Full Text] [Related]
19. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene. Rigas JR; Dragnev KH Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250 [TBL] [Abstract][Full Text] [Related]
20. Current strategies for anticancer chemoprevention and chemoprotection. Krzystyniak KL Acta Pol Pharm; 2002; 59(6):473-8. PubMed ID: 12669776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]